Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
112K
-
Shares change
-
+18.4K
-
Total reported value, excl. options
-
$38.3M
-
Value change
-
+$6.27M
-
Number of buys
-
29
-
Number of sells
-
-14
-
Price
-
$340.70
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q3 2025
51 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q3 2025.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112K shares
of 1.39B outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include Asset Management One Co., Ltd. (19.9K shares), Slow Capital, Inc. (18K shares), Voya Investment Management LLC (15.5K shares), Janney Montgomery Scott LLC (7.38K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (7.1K shares), TEMA ETFS LLC (6.77K shares), JGP Global Gestao de Recursos Ltda. (5.14K shares), WESPAC Advisors SoCal, LLC (3.12K shares), SG Americas Securities, LLC (2.79K shares), and SANDERS MORRIS HARRIS LLC (2.7K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.